Xiaochen Yu

33 papers receiving 1.2k citations

Xiaochen Yu's Hit Papers

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart 2019 · 491 citations
4910+2+4Years since publication100200300400

Peers

Xiaochen Yu
Comparison fields: 5 of 75
  • Endocrinology, Diabetes and Metabolism 371
  • Nephrology 131
  • Cardiology and Cardiovascular Medicine 320
  • Molecular Biology 300
  • Complementary and alternative medicine 36
Replace Mitchel Tate with:
Mitchel Tate Australia
Yunfeng Shen China
Yi Lin United States
Sung‐Hee Ihm South Korea
Mizuo Mifune Japan
Meena Asmar Denmark
I‐Hsien Wu United States
Kyoungmin Park United States
Zhuofeng Lin China
Lei Meng China
Xiaochen Yu relative to Mitchel Tate Australia Mitchel Tate's profile →
Citations per field
00.5×1.5×2.0×
Mitchel Tate · 1×
Citations per year

Countries citing papers authored by Xiaochen Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaochen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Yu more than expected).

Fields of papers citing papers by Xiaochen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Yu. The network helps show where Xiaochen Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaochen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaochen Yu Line = papers co-authored together Xiaochen Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Hit paper breakdown →
2019491
2 2020107
3 201993
4 201968
5 201960
6 201959
7 201947
8 202136
9 202128
10 201727
11 202125
12 202324
13 201922
14 202117
15 202217
16 202217
17 202115
18 201713
19 202113
20 201412

About Xiaochen Yu

Xiaochen Yu is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology, Nephrology, Molecular Biology and Cell Biology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (6 papers), Diabetes Treatment and Management (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Protein Hydrolysis and Bioactive Peptides (4 papers), Autophagy in Disease and Therapy (3 papers), Muscle metabolism and nutrition (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (371 citations), Nephrology (131 citations), Cardiology and Cardiovascular Medicine (320 citations), Molecular Biology (300 citations) and Complementary and alternative medicine (36 citations). Xiaochen Yu has collaborated with scholars based in China, Spain and United States. Frequent co-authors include Liming Chen, Bei Sun, Mei Xue, Linxin Xu, Ying Cheng, Yunhong Lu, Xiangyang Liu, Xiaoyu Li, Jie Zhang and Chenguang Li. Their work appears in journals such as Nutrients, Frontiers in Physiology, Biochemical and Biophysical Research Communications, Frontiers in Pharmacology and Frontiers in Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact